Results for ".l"

in healthy women: Non-pregnant premenopausal women: 97.5% of women have results ≤ 1 IU/L Postmenopausal women: 97.5% of women have results ≤ 7 IU/L (

Reference ranges Cut-offs at 6 hours post Chest Pain: <14 ng/L Normal Troponin. 14-30 ng/L Indeterminate Troponin: Cannot exclude Acute Coronary Syndrome

Therapeutic ranges Within 6 months post transplant: 10 - 15 µg/L After 6 months post transplant: 5 - 10 µg/L Further information To learn more about sirolimus

Results After 6 months, the PTH (51 to 58 pmol/l) calcium (2.45 to 2.38 mmol/L), and phosphate (1.81 to 1.90 mmol/L) were not significantly altered.

using the Cobas-Elecsys CA125 II ECLIA assay in 593 samples from healthy females (pre and post-menopausal) yielded a value of 35 kU/L (95th percentile

A progesterone level of greater than 30nmol/L should be seen as a guideline to ovulation rather than an absolute measure.

Reference ranges  Adult (male & female) < 1 IU/L Post-menopausal & mid cycle <3 IU/L Note: In pregnancy there is 0.1% cross-reactivity with hCG.

Reference ranges Serum/plasma iron 11 - 38 µmol/L Serum transferrin Male 1.8 - 3.3 g/L Female 1.9 - 3.8 g/L Transferrin saturation Referrals for HFE Genetic

Pool, L.

Reference ranges See most recent MHRA guidance for monitoring patients with MoM hip joints Cobalt Less than 10 nmol/L Chromium Less than 40 nmol/L Further

In clear cut deficiency, levels of B12 are nearly always <145 ng/l and usually <100 ng/l.

Reference ranges Fasting plasma beta-hydroxybutyrate: <0.3 mmol/L Fasting plasma free fatty acids: 0.10 - 0.90 mmol/L Further information To learn more

Reference ranges Less than 5 mg/L for adults.

Reference ranges Male Less than 50 U/L Female Less than 35 U/L Further information Lab Tests Online Analyte Monograph alongside the National Laboratory

During pregnancy the blood glucose targets are as follows: less than 5.3mmol/L pre meals less than 7.8mmol/L one hour post meals less than 6.4mmol/L two-hour

LH (IU/L)

Reference ranges Cardiovascular risk increases with Lp(a) >75 nmol/L. Values >125 nmol/L are designated high risk by the EAS/ESC guidelines.

Reference ranges Male: Less than 50 U/L Female: Less than 35 U/L Significantly raised ALT (> 3 x ULN) or persistently mildly raised ALT (for 3 - 6 months

Reference range g/L

Therapeutic level for the treatment of headache is 50 mg/L. All patients who have taken a deliberate overdose should be referred for assessment.